Newsgroup: it.scienza.medicina
Titolo: Vitamina C e Cancro

VITAMINA C e Cancro:
Studio pubblicato nel Canadian Medical Association Journal mostra in maniera 
convincente come la vitamina C per via endovenosa abbia represso in maniera 
documentata il cancro avanzato in tre casi riguardanti cancro alla vescica, 
polmone, rene e linfoma. Questi tre casi sono stati trattati con i rigidi 
standards dei case report stabiliti dall'U.S. National Cancer Institute.
Articolo reperibile su: Intravenously administered vitamin C as cancer 
therapy: three cases, Sebastian J. Padayatty, Hugh D. Riordan, Stephen M. 
Hewitt, Arie Katz, L. John Hoffer and Mark Levine. CMAJ Canadian Medical 
Association Journal. March 28, 2006; 174 (7). doi:10.1503/cmaj.050346
Ulteriore e recentissime info sulla vitamina C endovena con spiegazione del 
protocollo, affermano anche che e' estremamente pericolosa perche' attacca 
il tumore troppo efficacemente e crea conseguente intossicazione dell' 
organismo per necrosi del tumore ed incapacita' all'eliminazione (crisi di 
eliminazione) !
Quindi da scartare perche' pericolosa. "Guarisce" troppo in fretta !!
As indicated in the precautions, a small starting dose of 15 gram AA in 250 
mL RL over 1 hour is recommended. The patient is watched closely for any 
adverse effects. The dose can then be gradually increased over time. The 
infusion rate should not exceed 1 gram AA per minute; 0.5 gram/min is well 
tolerated by most patients. Although there is variability due to scheduling 
and tolerance, a typical protocol will consist of the following infusions:
Week 1: 1 x 15 g infusion per day, 2-3 per week
Week 2: 1 x 30 g infusion per day, 2-3 per week
Week 3: 1 x 65 g infusion per day, 2-3 per week
The dose is then adjusted to achieve transient plasma concentrations of 400 
mg/dL, 2-3 infusions per week.
RECNAC is a project of the Bio-Communications Research Institute, a division 
of The Center for the Improvement of Human Functioning International
Acute reactions to mega ascorbic acid therapy in malignant disease.
Scott Med J.  1979; 24(2):151-3 (ISSN: 0036-9330) Campbell A; Jack T
Three cases are described, 2 of Hodgkin's disease and a further case of 
bronchial carcinoma, where high dosage ascorbic acid treatment appeared to 
be associated with the development of potentially dangerous symptoms. It is 
suggested that mega ascorbic acid therapy should be given with caution in 
malignant disease, with a slow build-up over several days to high levels of 
dosage.
http://www.medscape.com/medline/abstract/227054
Cosa ne pensate ?
G. Paolo Vanoli

Cosa ne pensate ?
che se si legge l ' articolo originale completo e' meglio .
qui ad esempio 
http://www.cmaj.ca/cgi/content/full/174/7/937
a:    Discussion 
None of these case histories provides definitive proof that intravenous
vitamin C therapy was responsible for the patient's unusually favourable
clinical course. It is often difficult to prove definitively that a given
treatment is responsible for a specific clinical outcome. 
When the treatment is unorthodox, alternative explanations, even if highly
unlikely, tend to be preferred.
traduzione
- Nessuno di questi tre casi fornisce la prova che la terapia intravenosa di
vit C: sia stata responsabile dell ' inusuale andamento favorevole.
- Quando il trattamento non e' ortodosso esiste una tendenza a preferire
spiegazioni alternative , anche se altamente improbabili .
Lo studio prende comunque  in esame tre ( 3 ) casi . 
Un po' pochini . 
Gli studi sulla  cura proposta da Pauling piu' di trent'anni fa di solito si
concludono con " saranno necessari ulteriori indagini " .
Vabbe' , ma in trent'anni ....  tutto qui ?  
-- 
sgas® UIN 69225877/[skype:sgas_sg]
" Convictions are more dangerous enemies of truth than lies" 
(Nietzsche) 
http://www.sgas.it/signatures.htm